Stockreport

Kairos Pharma Provides Shareholder Update

Kairos Pharma, Ltd.  (KAPA) 
PDF Company makes important progress in 2025 and looks ahead into 2026 LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmac [Read more]